Spanish Red Biotech Pipeline

Amgen

blinatumomab

Type: Biodrugs/ Drugs
Therapeutic area: Blood and Lymphatic systems
Indication: Newly diagnosed Philadelphia Chromosome (Ph) Negative B-Precursor Acute Lymphoblastic Leukemia (ALL)
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain